Laser Treatment For The Treatment Of Hyperlipidemia Phlegm Type Of Clinical Research

Hyperlipidemia atherosclerosis (AS), a major risk factor for cardiovascular and cerebrovascular diseases. Effective prevention and treatment of dyslipidemia is an important way of prevention and treatment of cardiovascular and cerebrovascular diseases.2002China National Nutrition and Health Survey results:up to18.6%of≥18-year-old population prevalence of dyslipidemia, dyslipidemia has become a widespread health problems of human society in the21st century. Western medicine research and treatment of this disease has achieved greater results, but long-term medication caused liver and kidney damage, rhabdomyolysis, withdrawal rebound awareness of the difficulty of the treatment of this disease and hyperlipidemia, low cure rate, control rate, a high incidence of the cost of treatment is expensive. By observing the impact of low-energy laser irradiation treatment of hyperlipidemia hyperviscosity phlegm and blood stasis type of clinical indicators, the study will evaluate the efficacy and safety of low-energy laser irradiation therapy for the prevention and treatment of cardiovascular and cerebrovascular diseases, provide objective basis. The other hand, for the better treatment of phlegm and blood stasis hyperlipidemia, hyperviscosity Integrative new ideas, because it can reduce the side effects, the cost of treatment can reduce, also in line with China’s national conditions and the health care system.Objective:treatment programs to low-energy laser irradiation apparatus for the test group, the pure western lipid lowering therapy for the control group, the expectations through clinical research, objective evaluation of low-energy laser instrument phlegm type hyperlipidemia treatment effect, especiallythe impact of clinical symptoms, blood lipid levels, and to evaluate the clinical efficacy and safety, and to provide an objective basis for healthcare applications.Methods:A total of eligible cases60cases, according to the random number table using randomized, divided into low-energy laser irradiation instrument irradiation plus basic treatment group (experimental group), and the pure western lipid treatment group (control group),30patients in eachspecified method, were evaluated after treatment of a course of treatment (2weeks). Then groups before and after treatment, and the before and after treatment were used for statistical analysis of the therapeutic effect of the two groups were compared, the expedition evaluate the efficacy and safety of low-energy laser irradiation therapy.Results:The results of the clinical trials show that treatment to improve patients’ main clinical indicators (serum cholesterol, low-density lipoprotein, high density lipoprotein cholesterol) and a number of clinical symptoms (heart palpitations, insomnia, pale mouth, eat less), treatmentbefore and after were statistically significant (P<0.05). Improve improve patient clinical indicators (serum cholesterol, low-density lipoprotein, high density lipoprotein cholesterol) and a number of clinical symptoms (heart palpitations, insomnia, pale mouth, eat less) between the two groups, P<0.05, there are statistics learning differences. Consider its therapeutic mechanism may be the purpose of low-energy laser irradiation on the blood proteins (enzymes and other functional proteins) molecular institutions change, physical and chemical effects by changing the energy, the body to produce a range of biological effects, and thus achieve improved blood lipids conditions.